$74k – $86k /yr
New, posted 24 minutes ago
Amgen entry-level jobs & internships
Open roles at Amgen
29 open roles in the US
$74k – $86k /yr
New, posted 54 minutes ago
$74k – $86k /yr
New, posted 1 hour ago
$74k – $86k /yr
2 days ago
$74k – $86k /yr
3 days ago
$35.34 – $41.20 /hr
5 days ago
$60k /yr
6 days ago
Undergraduate Intern R&D Oncology Research
Amgen · South San Francisco, CA
- Internship
- Summer 2027
- On-site
$60k /yr
6 days ago
$74k – $86k /yr
6 days ago
Undergrad Clinical Immunology Intern Summer 2027
Amgen · Thousand Oaks, CA
- Internship
- Summer 2027
- On-site
$60k /yr
1 week ago
$35.34 – $41.20 /hr
1 week ago
$74k – $86k /yr
1 week ago
$73k – $86k /yr
1 week ago
$60k /yr
1 week ago
$35.34 – $42.20 /hr
1 week ago
$60k /yr
1 week ago
$35.34 – $41.20 /hr
1 week ago
$74k – $86k /yr
2 weeks ago
$35.34 – $41.20 /hr
2 weeks ago
$35.34 – $41.20 /hr
2 weeks ago
$60k /yr
2 weeks ago
$35.34 – $41.20 /hr
2 weeks ago
$60k /yr
2 weeks ago
$60k /yr
3 weeks ago
$60k /yr
1 month ago
$35.34 – $41.83 /hr
1 month ago
$87k /yr
1 month ago
$87k /yr
1 month ago
$60k /yr
1 month ago
About Amgen
Amgen Inc. is a leading multinational biotechnology company headquartered in Thousand Oaks, California, USA. Founded in 1980, Amgen is dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Its mission is to serve patients by transforming scientific discoveries into medicines that improve lives, with a focus on areas such as oncology, cardiovascular disease, neuroscience, and inflammation. The company is recognized for pioneering biologics and leveraging advanced genetic research to address serious illnesses.
With over 25,000 employees worldwide, Amgen holds a strong position in the global biotech market, consistently ranking among the largest biotechnology firms by revenue. It has a diverse portfolio of approved medicines, including well-known biologics like Enbrel, Neulasta, and Prolia, as well as a robust pipeline of investigational therapies. Recently, Amgen has made headlines for strategic acquisitions, such as its purchase of Horizon Therapeutics in 2023, expanding its rare disease portfolio, and for advancing cutting-edge research in biosimilars and precision medicine. The company is also committed to sustainability and corporate responsibility, aiming to reduce its environmental footprint while maintaining high standards of scientific excellence.